- Corporate Officers - B
- Baker Bros. Advisors (gp) Llc
Insider Trading History of Baker Bros. Advisors (gp) Llc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Baker Bros. Advisors (gp) Llc since 2014.
This trader's CIK number is 1580575.
At the time of last reporting, Baker Bros. Advisors (gp) Llc was the Officer of Igm Biosciences, Inc.. (stock ticker symbol IGMS).
Also see all insider trading activities at Igm Biosciences, Inc..
Note that in the past
Baker Bros. Advisors (GP) LLC also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Genomic Health Inc (GHDX) by Baker Bros. Advisors (gp) Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | GHDX | 0 | $0 | 303,067 | $22,016,767 | 16,500 | $290,235 |
2018 | GHDX | 0 | $0 | 265,680 | $19,930,895 | 0 | $0 |
Yearly summary of insider trading at Entrada Therapeutics, Inc. (TRDA) by Baker Bros. Advisors (gp) Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | TRDA | 161,400 | $973,801 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Neoleukin Therapeutics, Inc. (NLTX) by Baker Bros. Advisors (gp) Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | NLTX | 3,017,542 | $25,347,352 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Mirati Therapeutics, Inc. (MRTX) by Baker Bros. Advisors (gp) Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | MRTX | 0 | $0 | 999,358 | $9,418,556 | 0 | $0 |
2015 | MRTX | 150,000 | $6,750,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Acadia Pharmaceuticals Inc (ACAD) by Baker Bros. Advisors (gp) Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | ACAD | 1,449,090 | $38,856,402 | 0 | $0 | 0 | $0 |
2014 | ACAD | 526,316 | $15,000,006 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Invitae Corp (NVTA) by Baker Bros. Advisors (gp) Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | NVTA | 733,333 | $4,399,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Seagen Inc. (SGEN) by Baker Bros. Advisors (gp) Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | SGEN | 0 | $0 | 0 | $0 | 17,500 | $642,250 |
2022 | SGEN | 0 | $0 | 0 | $0 | 35,000 | $702,100 |
Yearly summary of insider trading at Bellicum Pharmaceuticals, Inc (BLCM) by Baker Bros. Advisors (gp) Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | BLCM | 166,666 | $1,999,992 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Incyte Corp (INCY) by Baker Bros. Advisors (gp) Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | INCY | 800,000 | $50,975,199 | 0 | $0 | 60,000 | $231,600 |
2015 | INCY | 0 | $0 | 0 | $0 | 4,683,926 | $460,800 |
2014 | INCY | 0 | $0 | 0 | $0 | 30,000 | $210,600 |
Yearly summary of insider trading at Trimeris Inc (GEVA) by Baker Bros. Advisors (gp) Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | GEVA | 1,000,000 | $94,190,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aceragen, Inc. (IDRA) by Baker Bros. Advisors (gp) Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | IDRA | 5,333,333 | $19,999,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Intellia Therapeutics, Inc. (NTLA) by Baker Bros. Advisors (gp) Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | NTLA | 200,000 | $3,600,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Atreca, Inc. (BCEL) by Baker Bros. Advisors (gp) Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | BCEL | 0 | $0 | 274,739 | $110,719 | 0 | $0 |
Yearly summary of insider trading at Igm Biosciences, Inc. (IGMS) by Baker Bros. Advisors (gp) Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | IGMS | 395,317 | $3,425,721 | 0 | $0 | 0 | $0 |
2023 | IGMS | 532,693 | $3,390,965 | 0 | $0 | 0 | $0 |
Insider trading activities at 14 companies by Baker Bros. Advisors (gp) Llc:
1. Genomic Health Inc (GHDX)
2. Entrada Therapeutics, Inc. (TRDA)
3. Neoleukin Therapeutics, Inc. (NLTX)
4. Mirati Therapeutics, Inc. (MRTX)
5. Acadia Pharmaceuticals Inc (ACAD)
6. Invitae Corp (NVTA)
7. Seagen Inc. (SGEN)
8. Bellicum Pharmaceuticals, Inc (BLCM)
9. Incyte Corp (INCY)
10. Trimeris Inc (GEVA)
11. Aceragen, Inc. (IDRA)
12. Intellia Therapeutics, Inc. (NTLA)
13. Atreca, Inc. (BCEL)
14. Igm Biosciences, Inc. (IGMS)
Table 1. Insider trading of Genomic Health Inc (GHDX) by Baker Bros. Advisors (gp) Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-02-27 | GHDX | Sale | 39,109 | 76.43 | 2,989,139 |
2019-02-26 | GHDX | Option Ex | 16,500 | 17.59 | 290,235 |
2019-02-26 | GHDX | Sale | 8,650 | 77.97 | 674,440 |
2019-01-28 | GHDX | Sale | 46,477 | 70.95 | 3,297,636 |
2019-01-23 | GHDX | Sale | 37,512 | 71.99 | 2,700,338 |
2019-01-24 | GHDX | Sale | 79,403 | 72.02 | 5,718,604 |
2019-01-25 | GHDX | Sale | 91,916 | 72.20 | 6,636,610 |
2018-11-26 | GHDX | Sale | 39,675 | 74.20 | 2,944,043 |
2018-11-27 | GHDX | Sale | 138,610 | 74.00 | 10,257,001 |
2018-11-16 | GHDX | Sale | 87,395 | 77.00 | 6,729,851 |
Table 2. Insider trading of Entrada Therapeutics, Inc. (TRDA) by Baker Bros. Advisors (gp) Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-06-06 | TRDA | Buy | 38,304 | 6.39 | 244,685 |
2022-06-02 | TRDA | Buy | 2,643 | 5.82 | 15,382 |
2022-05-20 | TRDA | Buy | 16,849 | 5.84 | 98,431 |
2022-05-24 | TRDA | Buy | 23,823 | 5.84 | 139,031 |
2022-05-23 | TRDA | Buy | 7,837 | 5.99 | 46,920 |
2022-05-16 | TRDA | Buy | 19,000 | 5.83 | 110,694 |
2022-05-17 | TRDA | Buy | 18,511 | 6.13 | 113,472 |
2022-05-18 | TRDA | Buy | 34,433 | 5.96 | 205,186 |
Table 3. Insider trading of Neoleukin Therapeutics, Inc. (NLTX) by Baker Bros. Advisors (gp) Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-12-20 | NLTX | Buy | 3,017,542 | 8.40 | 25,347,352 |
Table 4. Insider trading of Mirati Therapeutics, Inc. (MRTX) by Baker Bros. Advisors (gp) Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-06-07 | MRTX | Sale | 296,200 | 9.44 | 2,795,535 |
2016-06-08 | MRTX | Sale | 158,100 | 9.21 | 1,456,417 |
2016-06-09 | MRTX | Sale | 545,058 | 9.48 | 5,166,604 |
2015-09-16 | MRTX | Buy | 150,000 | 45.00 | 6,750,000 |
Table 5. Insider trading of Acadia Pharmaceuticals Inc (ACAD) by Baker Bros. Advisors (gp) Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-03-30 | ACAD | Buy | 462,546 | 26.08 | 12,064,124 |
2016-04-01 | ACAD | Buy | 302,900 | 28.18 | 8,536,933 |
2016-03-31 | ACAD | Buy | 683,644 | 26.70 | 18,255,345 |
2014-03-05 | ACAD | Buy | 526,316 | 28.50 | 15,000,006 |
Table 6. Insider trading of Invitae Corp (NVTA) by Baker Bros. Advisors (gp) Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-11-17 | NVTA | Buy | 733,333 | 6.00 | 4,399,998 |
Table 7. Insider trading of Seagen Inc. (SGEN) by Baker Bros. Advisors (gp) Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-05-01 | SGEN | Option Ex | 17,500 | 36.70 | 642,250 |
2022-03-08 | SGEN | Option Ex | 35,000 | 20.06 | 702,100 |
Table 8. Insider trading of Bellicum Pharmaceuticals, Inc (BLCM) by Baker Bros. Advisors (gp) Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-03-24 | BLCM | Buy | 166,666 | 12.00 | 1,999,992 |
Table 9. Insider trading of Incyte Corp (INCY) by Baker Bros. Advisors (gp) Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-03-15 | INCY | Buy | 400,000 | 66.08 | 26,431,599 |
2016-03-17 | INCY | Buy | 400,000 | 61.36 | 24,543,600 |
2016-03-17 | INCY | Option Ex | 60,000 | 3.86 | 231,600 |
2015-09-16 | INCY | Option Ex | 4,623,926 | .00 | 0 |
2015-05-11 | INCY | Option Ex | 60,000 | 7.68 | 460,800 |
2014-05-21 | INCY | Option Ex | 30,000 | 7.02 | 210,600 |
Table 10. Insider trading of Trimeris Inc (GEVA) by Baker Bros. Advisors (gp) Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-01-07 | GEVA | Buy | 1,000,000 | 94.19 | 94,190,000 |
Table 11. Insider trading of Aceragen, Inc. (IDRA) by Baker Bros. Advisors (gp) Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-02-13 | IDRA | Buy | 5,333,333 | 3.75 | 19,999,998 |
Table 12. Insider trading of Intellia Therapeutics, Inc. (NTLA) by Baker Bros. Advisors (gp) Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-05-11 | NTLA | Buy | 200,000 | 18.00 | 3,600,000 |
Table 13. Insider trading of Atreca, Inc. (BCEL) by Baker Bros. Advisors (gp) Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-10-19 | BCEL | Sale | 274,739 | .40 | 110,719 |
Table 14. Insider trading of Igm Biosciences, Inc. (IGMS) by Baker Bros. Advisors (gp) Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-03-27 | IGMS | Buy | 27,844 | 9.24 | 257,389 |
2024-03-28 | IGMS | Buy | 97,473 | 9.62 | 937,592 |
2024-03-26 | IGMS | Buy | 270,000 | 8.26 | 2,230,740 |
2023-12-15 | IGMS | Buy | 288,007 | 6.44 | 1,854,765 |
2023-12-13 | IGMS | Buy | 87,316 | 5.88 | 512,981 |
2023-12-14 | IGMS | Buy | 157,370 | 6.50 | 1,023,219 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Baker Bros. Advisors (gp) Llc
(Officer of Igm Biosciences, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.